{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:52:29Z","timestamp":1778043149779,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,4,19]],"date-time":"2013-04-19T00:00:00Z","timestamp":1366329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s00784-013-0979-2","type":"journal-article","created":{"date-parts":[[2013,4,18]],"date-time":"2013-04-18T04:28:57Z","timestamp":1366259337000},"page":"391-399","source":"Crossref","is-referenced-by-count":28,"title":["Relevance of surgical management of patients affected by bisphosphonate-associated osteonecrosis of the jaws. A prospective clinical and radiological study"],"prefix":"10.1007","volume":"18","author":[{"given":"Philippe","family":"Lesclous","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Grabar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Semaan","family":"Abi Najm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Carrel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"Saffar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacky","family":"Samson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,19]]},"reference":[{"key":"979_CR1","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L","volume":"88","author":"MJ Rogers","year":"2000","unstructured":"Rogers MJ, Gordon S, Benford HL, Coxon FP, Luckman SP, Monkkonen J, Frith JC (2000) Cellular and molecular mechanisms of action of bisphosphonates. Cancer 88:2961\u20132978","journal-title":"Cancer"},{"key":"979_CR2","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0278-2391(03)00328-8","volume":"61","author":"J Wang","year":"2003","unstructured":"Wang J, Goodger NM, Pogrel MA (2003) Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 61:1104\u20131107","journal-title":"J Oral Maxillofac Surg"},{"key":"979_CR3","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and Zoledronate (Zometa) induced vascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115\u20131117","journal-title":"J Oral Maxillofac Surg"},{"key":"979_CR4","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","volume":"22","author":"S Khosla","year":"2007","unstructured":"Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, Gagel RF, Gilsanz V, Guise T, Koka S, Mc Cauley LK, Mc Gowan J, Mc Kee MD, Mohla S, Pendrys DG, Raisz LG, Ruggiero SL, Shafer DM, Shum L, Silverman SL, Van Poznak CH, Watts N, Woo SB, Shane E (2007) Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22:1479\u20131491","journal-title":"J Bone Miner Res"},{"key":"979_CR5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","volume":"353","author":"BGM Durie","year":"2005","unstructured":"Durie BGM, Katz M, Crowley J (2005) Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 353:99\u2013100","journal-title":"N Engl J Med"},{"key":"979_CR6","first-page":"8580","volume":"34","author":"A Bamias","year":"2006","unstructured":"Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnostopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA (2006) Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 34:8580\u20138585","journal-title":"J Clin Oncol"},{"key":"979_CR7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1749-6632.2010.05771.x","volume":"1218","author":"AO Hoff","year":"2010","unstructured":"Hoff AO, Toth B, Hu M, Hortobagyi GN, Gagel RF (2010) Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients. Ann NY Acad Sci 1218:47\u201354","journal-title":"Ann NY Acad Sci"},{"key":"979_CR8","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.bone.2008.01.003","volume":"42","author":"R Rizzoli","year":"2008","unstructured":"Rizzoli R, Burlet N, Cahall D, Delmas PD, Eriksen EF, Felsenberg D, Grbic J, Jontell M, Landesberg R, Laslop A, Wollenhaupt M, Papapoulos S, Sezer O, Sprafka M, Reginster R (2008) Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. Bone 42:841\u2013847","journal-title":"Bone"},{"key":"979_CR9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1749-6632.2010.05835.x","volume":"1218","author":"R Landesberg","year":"2011","unstructured":"Landesberg R, Woo V, Cremers S, Cozin M, Marolt D, Vunjak-Novakovic G, Kousteni S, Raghavan S (2011) Potential pathophysiological mechanisms in osteonecrosis of the jaw. Ann NY Acad Sci 1218:62\u201379","journal-title":"Ann NY Acad Sci"},{"key":"979_CR10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.joms.2009.01.007","volume":"67","author":"MR Allen","year":"2009","unstructured":"Allen MR, Burr DB (2009) The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data. J Oral Maxillofac Surg 67:61\u201370","journal-title":"J Oral Maxillofac Surg"},{"issue":"Suppl","key":"979_CR11","first-page":"502","volume":"22","author":"R Baron","year":"1977","unstructured":"Baron R, Saffar JL, Duflot-Vignery A (1977) Alveolar bone remodeling in the rat: normal status and effects of PTX and PTH on remodeling sequence and the osteoblastic pool. Calcif Tissue Res 22(Suppl):502\u2013504","journal-title":"Calcif Tissue Res"},{"issue":"Suppl 2","key":"979_CR12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/jbmr.5650140212","volume":"14","author":"RG Russel","year":"1999","unstructured":"Russel RG, Rogers MJ, Frith JC, Luckman SP, Coxon FP, Benford HL, Croucher PI, Shipman C, Fleisch HA (1999) The pharmacology of bisphosphonates and new insights into their mechanisms of action. J Bone Miner Res 14(Suppl 2):53\u201365","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"979_CR13","first-page":"2","volume":"67","author":"SL Ruggiero","year":"2009","unstructured":"Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B (2009) American association of oral and maxillofacial surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20132009 update. J Oral Maxillofac Surg 67(Suppl 1):2\u201312","journal-title":"J Oral Maxillofac Surg"},{"key":"979_CR14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.ebd.6400608","volume":"9","author":"D Richards","year":"2008","unstructured":"Richards D (2008) Guidelines for bisphosphonate associated osteonecrosis of the jaw. Evid Based Dent 9:101\u2013102","journal-title":"Evid Based Dent"},{"key":"979_CR15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.joms.2005.12.051","volume":"65","author":"MM Curi","year":"2007","unstructured":"Curi MM, Cossolin GSI, Koga DH, Ara\u00f9jo SR, Feber O, dos Santos MO, Zardetto C (2007) Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich factor: report of three cases. J Oral Maxillofac Surg 65:349\u2013355","journal-title":"J Oral Maxillofac Surg"},{"key":"979_CR16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.critrevonc.2008.10.009","volume":"71","author":"M Tubiana-Hulin","year":"2009","unstructured":"Tubiana-Hulin M, Spielmann M, Roux C, Campone M, Zelek L, Gligorov J, Samson J, Lesclous P, Laredo JD, Namer M (2009) Physiopathology and management of osteonecrosis of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysis. Crit Rev Oncol Hematol 71:12\u201321","journal-title":"Crit Rev Oncol Hematol"},{"issue":"Suppl 1","key":"979_CR17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.joms.2009.01.006","volume":"67","author":"ER Carlson","year":"2009","unstructured":"Carlson ER, Basile JD (2009) The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 67(Suppl 1):85\u201395","journal-title":"J Oral Maxillofac Surg"},{"key":"979_CR18","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bone.2009.07.011","volume":"45","author":"P Lesclous","year":"2009","unstructured":"Lesclous P, Abi Najm S, Carrel JP, Baroukh B, Lombardi T, Willi JP, Rizzoli R, Saffar JL, Samson J (2009) Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation? Bone 45:843\u2013852","journal-title":"Bone"},{"key":"979_CR19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijom.2009.11.014","volume":"39","author":"RA Williamson","year":"2010","unstructured":"Williamson RA (2010) Surgical management of bisphosphonate induced osteonecrosis of the jaws. Int J Oral Maxillofac Surg 39:251\u2013255","journal-title":"Int J Oral Maxillofac Surg"},{"key":"979_CR20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tripleo.2010.04.015","volume":"111","author":"F Wilde","year":"2011","unstructured":"Wilde F, Heufelder M, Winter K, Hendricks J, Frerich B, Schramm A, Hemprich A (2011) The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 111:153\u2013168","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"979_CR21","author":"D Holzinger","year":"2012","unstructured":"Holzinger D, Seeman R, Klug C, Ewers R, Millesi G, Baumann A, Wurtzl A (2012) Long-term success of surgery in bisphosphonate-related osteonecrosis of the jaws (BRONJs). Oral Oncol. doi: 10.1016\/j.oraloncology2012.07.008","journal-title":"Oral Oncol"},{"key":"979_CR22","author":"J Lemound","year":"2012","unstructured":"Lemound J, Eckardt A, Kokem\u00fcller H, von See C, Vos PJ, Tavassol F, R\u00fccker M, Rana M, Gellrich NC (2012) Bisphosphonate-associated osteonecrosis of the mandible: reliable soft tissue reconstruction using a myofascial flap. Clin Oral Invest. doi: 10.1007\/s00784-011-0596-x","journal-title":"Clin Oral Invest"},{"key":"979_CR23","author":"AL Watters","year":"2012","unstructured":"Watters AL, Hansen HJ, Williams T, Chou JF, Riedel E, Halpern J, Tunick S, Bohle G, Huryn JM, Estilo CL (2012) Intravenous bisphosphonate-related osteonecrosis of the jaw: long term follow-up of 109 patients. Oral Surg Oral Med Oral Pathol Oral Radiol. doi: 10.1016\/j.OOOO.2012.05.017","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"979_CR24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","volume":"65","author":"American Association of Oral and Maxillofacial Surgeons","year":"2007","unstructured":"American Association of Oral and Maxillofacial Surgeons (2007) Position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65:369\u2013376","journal-title":"J Oral Maxillofac Surg"},{"key":"979_CR25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/annonc\/mdn630","volume":"20","author":"T Wyngaert Van den","year":"2008","unstructured":"Van den Wyngaert T, Claeys T, Huizing MT, Vermorken JB, Fossion E (2008) Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome. Ann Oncol 20:331\u2013336","journal-title":"Ann Oncol"},{"key":"979_CR26","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.joms.2010.06.200","volume":"69","author":"S Hoefert","year":"2011","unstructured":"Hoefert S, Eufinger H (2011) Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw. J Oral Maxillofac Surg 69:362\u2013380","journal-title":"J Oral Maxillofac Surg"},{"key":"979_CR27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00520-009-0688-1","volume":"18","author":"P Stockmann","year":"2010","unstructured":"Stockmann P, Vairaktaris E, Wehrhan F, Seiss M, Schwartz S, Spriewald B, Neukam FW, Nkenke E (2010) Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12\u00a0months follow-up. Support Care Cancer 18:449\u2013460","journal-title":"Support Care Cancer"},{"key":"979_CR28","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1359\/jbmr.080205","volume":"23","author":"AO Hoff","year":"2008","unstructured":"Hoff AO, Toth BB, Altundag K, Johnson MM, Wameke CL, Hu M, Nooka A, Sayegh G, Guarneri V, Desrouleaux K, Cuj J, Adamus A, Gapel RF, Hortobaqyi GN (2008) The frequency and risk factors associated with ONJ in cancer patients treated with intravenous bisphosphonate. J Bone Miner Res 23:826\u2013836","journal-title":"J Bone Miner Res"},{"key":"979_CR29","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.oraloncology.2007.11.012","volume":"44","author":"T Boonyapakorn","year":"2008","unstructured":"Boonyapakorn T, Schirmer I, Reichart PA, Sturm I, Massenkeil G (2008) Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies. Oral Oncol 44:857\u2013869","journal-title":"Oral Oncol"},{"key":"979_CR30","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0022034510397196","volume":"90","author":"A Barasch","year":"2011","unstructured":"Barasch A, Cunha-Cruz J, Curro FA, Cunha-Cruz J, Curro FA, Hujoel P, Sung AH, Vena D, Voinea-Griffin AE, Beadnell S, Craig RG, DeRouen T, Desaranayake A, Gilbert A, Gilbert GH, Goldberg K, Hauley R, Hashimoto M, Holmes J, Latzke B, Leroux B, Lindblad A, Richman J, Safford M, Ship J, Thompson VP, Williams OD, Yin W, CONDOR Collaborative Group (2011) Risk factors for osteonecrosis of the jaws: a case\u2013control study from the CONDOR dental PBRN. J Dent Res 90:439\u2013444","journal-title":"J Dent Res"},{"key":"979_CR31","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.14219\/jada.archive.2011.0108","volume":"142","author":"JW Hellstein","year":"2011","unstructured":"Hellstein JW, Adler RA, Edwards B, Jacobsen PL, Kalmar JR, Koka S, Migliorati CA, Ristic H (2011) Managing care of the patients receiving antiresorptive therapy for prevention and treatment of osteoporosis. Executive summary of recommendations from the American Dental Association Council on scientific affairs expert panel on antiresorptive agents. J Am Dent Assoc 142:1243\u20131251","journal-title":"J Am Dent Assoc"},{"key":"979_CR32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","volume":"353","author":"BG Durie","year":"2005","unstructured":"Durie BG, Katz M, Crowley J (2005) ONJ and bisphosphonates. N Engl J Med 353:99\u2013100","journal-title":"N Engl J Med"},{"key":"979_CR33","first-page":"613","volume":"85","author":"N Wowern von","year":"1977","unstructured":"von Wowern N (1977) Variations in structure within the trabecular bone of the mandible. Scand J Dent Res 85:613\u2013622","journal-title":"Scand J Dent Res"},{"key":"979_CR34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-0757.1997.tb00096.x","volume":"13","author":"JL Saffar","year":"1997","unstructured":"Saffar JL, Lasfargues JJ, Cherruau M (1997) Alveolar bone and the alveolar process: the socket is never stable. Periodontol 2000 13:76\u201390","journal-title":"Periodontol 2000"},{"key":"979_CR35","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bone.2007.04.196","volume":"41","author":"IR Reid","year":"2007","unstructured":"Reid IR, Bolland MJ, Grey AB (2007) Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone 41:318\u2013320","journal-title":"Bone"},{"key":"979_CR36","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","volume":"144","author":"SB Woo","year":"2006","unstructured":"Woo SB, Hellstein JW, Kalmar JR (2006) Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144:753\u2013761","journal-title":"Ann Intern Med"},{"key":"979_CR37","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.joms.2008.01.026","volume":"66","author":"R Landesberg","year":"2008","unstructured":"Landesberg R, Cozin M, Cremers S, Woo V, Kousteni S, Sinha S, Garrett-Sinha LA, Raghavan S (2008) Inhibition of oral mucosal cell wound healing by bisphosphonates. J Oral Maxillofac Surg 66:839\u2013847","journal-title":"J Oral Maxillofac Surg"},{"key":"979_CR38","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2141.2008.07504.x","volume":"144","author":"MA Scheper","year":"2009","unstructured":"Scheper MA, Badros A, Chaisupara R, Cullen KJ, Meiller TF (2009) Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis. Br J Haematol 144:667\u2013676","journal-title":"Br J Haematol"},{"key":"979_CR39","author":"M Mozzati","year":"2012","unstructured":"Mozzati M, Martinasso G, Maggiora M, Scoletta M, Zambelli M, Carossa S, Oraldi M, Muzio G, Canuto RA (2012) Oral mucosa produces cytokines and factors influencing osteoclast activity and endothelial cell proliferation, in patients with osteonecrosis of jaw after treatment with zoledronic acid. Clin Oral Invest. doi: 10.1007\/s00784-012-0800-7","journal-title":"Clin Oral Invest"},{"key":"979_CR40","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.bone.2011.07.020","volume":"49","author":"J Cornish","year":"2011","unstructured":"Cornish J, Bava U, Callon KE, Bai J, Naot D, Reid IR (2011) Bone-bound bisphosphonate inhibits growth of adjacent non-bone cells. Bone 49:710\u2013716","journal-title":"Bone"},{"key":"979_CR41","first-page":"968","volume":"91","author":"MA Dimopoulos","year":"2007","unstructured":"Dimopoulos MA, Kastritis E, Anagnostopoulos A, Melekapopoulos I, Gika D, Moulopoulos LA, Bamia C, Terpos E, Tsionos K, Bamias A (2007) Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid. Hematological 91:968\u2013971","journal-title":"Hematological"},{"key":"979_CR42","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.critrevonc.2007.07.005","volume":"64","author":"IJ Diel","year":"2007","unstructured":"Diel IJ, Fogelman I, Al-Nawas B, Hoffmeister B, Migliorati C, Gligorov J, V\u00e4\u00e4n\u00e4nen K, Pylkk\u00e4nen L, Pecherstorfer M, Aapro MS (2007) Pathophysiology, risk factor, and management of bisphosphonate-associated osteonecrosis of the jaw: is there a diverse relationship of amino- and non-aminobisphosphonates? Crit Rev Oncol Hematol 64:198\u2013207","journal-title":"Crit Rev Oncol Hematol"},{"key":"979_CR43","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1470-2045(06)70726-4","volume":"7","author":"CA Migliorati","year":"2006","unstructured":"Migliorati CA, Siegel MA, Elting LS (2006) Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment. Lancet Oncol 7:508\u2013514","journal-title":"Lancet Oncol"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-013-0979-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00784-013-0979-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-013-0979-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T15:44:55Z","timestamp":1562946295000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00784-013-0979-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,19]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["979"],"URL":"https:\/\/doi.org\/10.1007\/s00784-013-0979-2","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,19]]}}}